Cargando…

Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors

ESSENTIALS: There is scant data on surgery shortly after intake of rivaroxaban. We performed neurosurgery using high dose PCCs and tranexamic acid. Intraoperative haemostasis was good and no transfusion was needed. There was no delayed postoperative haemotoma or thromboembolic complication. We prese...

Descripción completa

Detalles Bibliográficos
Autores principales: De Vlieger, Jan, Dietvorst, Sofie, Demaerel, Rik, Verhamme, Peter, Nuttin, Bart, Vanassche, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058271/
https://www.ncbi.nlm.nih.gov/pubmed/30046700
http://dx.doi.org/10.1002/rth2.12035
_version_ 1783341662324391936
author De Vlieger, Jan
Dietvorst, Sofie
Demaerel, Rik
Verhamme, Peter
Nuttin, Bart
Vanassche, Thomas
author_facet De Vlieger, Jan
Dietvorst, Sofie
Demaerel, Rik
Verhamme, Peter
Nuttin, Bart
Vanassche, Thomas
author_sort De Vlieger, Jan
collection PubMed
description ESSENTIALS: There is scant data on surgery shortly after intake of rivaroxaban. We performed neurosurgery using high dose PCCs and tranexamic acid. Intraoperative haemostasis was good and no transfusion was needed. There was no delayed postoperative haemotoma or thromboembolic complication. We present a patient who underwent urgent neurosurgery for acute onset paraplegia due to a spontaneous subdural spinal hematoma less than 5 hours after she had taken rivaroxaban. The Key Clinical Question was whether early high‐risk surgery on a patient taking direct oral anticoagulants is feasible. Prothrombin complex concentrate (PCC) and tranexamic acid were administered and perioperative hemostasis was good. There is scant data on neurosurgical procedures performed within 12 hours after the intake of a direct oral anticoagulant. With the hemostatic support of high‐dose PCC, early surgery after administration of rivaroxaban seems feasible in case of an emergency indication, but should only be considered when delaying surgery is esteemed hazardous to the patient. More experience is needed to allow balancing risks and benefits of urgent vs delayed intervention and on the optimal hemostatic support in the absence of a specific antidote.
format Online
Article
Text
id pubmed-6058271
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-60582712018-07-25 Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors De Vlieger, Jan Dietvorst, Sofie Demaerel, Rik Verhamme, Peter Nuttin, Bart Vanassche, Thomas Res Pract Thromb Haemost Case Reports ESSENTIALS: There is scant data on surgery shortly after intake of rivaroxaban. We performed neurosurgery using high dose PCCs and tranexamic acid. Intraoperative haemostasis was good and no transfusion was needed. There was no delayed postoperative haemotoma or thromboembolic complication. We present a patient who underwent urgent neurosurgery for acute onset paraplegia due to a spontaneous subdural spinal hematoma less than 5 hours after she had taken rivaroxaban. The Key Clinical Question was whether early high‐risk surgery on a patient taking direct oral anticoagulants is feasible. Prothrombin complex concentrate (PCC) and tranexamic acid were administered and perioperative hemostasis was good. There is scant data on neurosurgical procedures performed within 12 hours after the intake of a direct oral anticoagulant. With the hemostatic support of high‐dose PCC, early surgery after administration of rivaroxaban seems feasible in case of an emergency indication, but should only be considered when delaying surgery is esteemed hazardous to the patient. More experience is needed to allow balancing risks and benefits of urgent vs delayed intervention and on the optimal hemostatic support in the absence of a specific antidote. John Wiley and Sons Inc. 2017-08-10 /pmc/articles/PMC6058271/ /pubmed/30046700 http://dx.doi.org/10.1002/rth2.12035 Text en © 2017 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals, Inc on behalf of International Society on Thrombosis and Haemostasis. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
De Vlieger, Jan
Dietvorst, Sofie
Demaerel, Rik
Verhamme, Peter
Nuttin, Bart
Vanassche, Thomas
Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
title Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
title_full Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
title_fullStr Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
title_full_unstemmed Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
title_short Neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
title_sort neurosurgery in a patient at peak levels of rivaroxaban: taking into account all factors
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058271/
https://www.ncbi.nlm.nih.gov/pubmed/30046700
http://dx.doi.org/10.1002/rth2.12035
work_keys_str_mv AT devliegerjan neurosurgeryinapatientatpeaklevelsofrivaroxabantakingintoaccountallfactors
AT dietvorstsofie neurosurgeryinapatientatpeaklevelsofrivaroxabantakingintoaccountallfactors
AT demaerelrik neurosurgeryinapatientatpeaklevelsofrivaroxabantakingintoaccountallfactors
AT verhammepeter neurosurgeryinapatientatpeaklevelsofrivaroxabantakingintoaccountallfactors
AT nuttinbart neurosurgeryinapatientatpeaklevelsofrivaroxabantakingintoaccountallfactors
AT vanasschethomas neurosurgeryinapatientatpeaklevelsofrivaroxabantakingintoaccountallfactors